Market revenue in 2023 | USD 333.1 million |
Market revenue in 2030 | USD 566.4 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Oncology |
Fastest growing segment | Oncology |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiovascular, Dermatology, Orthopedics, Nephrology, Respiratory, Neurology, Oncology, ENT |
Key market players worldwide | SGS AG, Intertek Group PLC, Element Materials Technology, NAMSA, Eurofins Scientific SE, Charles River Laboratories International Inc, Sterling Check Corp, Toxikon, Steris PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device validation & verification market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 26.54% in 2023. Horizon Databook has segmented the North America medical device validation & verification market based on cardiovascular, dermatology, orthopedics, nephrology, respiratory, neurology, oncology, ent covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America medical device validation & verification market , including forecasts for subscribers. This continent databook contains high-level insights into North America medical device validation & verification market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account